Sort
17,828 grants matching “crispr”
TCR signaling strength regulated T cell differentiation during chronic viral infection
$350,000Weiguo Cui · Northwestern University At Chicago · R56 · FY2024 · AI
AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma
$350,000Chun-Hao Huang · Algen Biotechnologies Inc · R41 · FY2021 · GM
Designer Pichia Strains That Enable Difficult-To-Express Biologics Production by Addressing Limitations in Secretory Protein Expression
$350,000Shane Byrne · Codomax Inc. · R41 · FY2024 · TR
Collaborative Research: Data-driven engineering of the yeast Kluyveromyces marxianus for enhanced protein secretion
$350,000Ian Wheeldon · University Of California-Riverside · · FY2024 · ENG
EAGER: Development Of Functional Genetic Tools For Endoparasitoid Wasps
$350,000Todd A Schlenke · University Of Arizona · · FY2020 · BIO
Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia
$350,000Christopher E Hopkins · Nemametrix, Inc. · R43 · FY2018 · AG
An early-intervention gene-editing therapeutic for Pulmonary Arterial Hypertension
$350,000Vinod Jaskula-Ranga · Hunterian Medicine Llc · R43 · FY2023 · HL
Collaborative Research: Data-driven engineering of the yeast Kluyveromyces marxianus for enhanced protein secretion
$349,999Nancy A Da Silva · University Of California-Irvine · · FY2024 · ENG
High-throughput CRISPR-based Diagnostic Assay for Coronaviruses and Other Respiratory Diseases
$349,995Bruce W. Birren · Broad Institute, Inc. · U19 · FY2020 · AI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
$349,929Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2019 · CA
Modeling and targeting tumor-immune signaling interactions in tumor microenvironment
$349,875Fuhai Li · Washington University · R01 · FY2024 · LM
Modeling and targeting tumor-immune signaling interactions in tumor microenvironment
$349,874Fuhai Li · Washington University · R01 · FY2025 · LM
Wnt signaling in obesity-associated colorectal cancer
$349,874Jatin Roper · Duke University · R37 · FY2024 · CA
Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments
$349,857Mitchell Guttman · California Institute Of Technology · U01 · FY2019 · DA
Mays Cancer Center at UT Health SA
$349,820Yidong Chen · University Of Texas Hlth Science Center · P30 · FY2025 · CA
A Universal Tool for Unravelling the Requirements for Clinically Relevant Cell-Cell Interactions via In Situ Phenotyping and Tagging of Live Cells
$349,816John M Beierle · Narwhal Bio, Inc. · R43 · FY2024 · GM
In Vivo Gene Targeting to Treat Inherited Bone Disease
$349,800David R Deyle · Mayo Clinic Rochester · R01 · FY2015 · AR
In Vivo Gene Targeting to Treat Inherited Bone Disease
$349,800David R Deyle · Mayo Clinic Rochester · R01 · FY2017 · AR
In Vivo Gene Targeting to Treat Inherited Bone Disease
$349,800David R Deyle · Mayo Clinic Rochester · R01 · FY2018 · AR
In Vivo Gene Targeting to Treat Inherited Bone Disease
$349,800David R Deyle · Mayo Clinic Rochester · R01 · FY2020 · AR
Epigenetic disruptions of PBDEs during neurodevelopment
$349,791Ramendra N Saha · University Of California, Merced · R01 · FY2020 · ES
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$349,781Alexis C. Komor · University Of California, San Diego · R35 · FY2021 · GM
Molecular basis of tumor suppression by Cdk4/6 inhibition
$349,699Seth Michael Rubin · University Of California Santa Cruz · R01 · FY2022 · CA
Investigate and inhibit microglia support of brain metastases
$349,671Melanie Hayden Gephart · Stanford University · U54 · FY2025 · CA
Studies of Allostery between Multi-domain Proteins and Nucleic Acid Complexes
$349,363Victor S Batista · Yale University · R01 · FY2023 · GM